Is GHRP-2 FDA approved?
No. This site's US field is not approved, research use only. GHRP-2, also called pralmorelin, is approved in Japan as a test of how much growth hormone the pituitary releases, not as a treatment. That Japanese test approval does not carry over to the FDA. It is not licensed in the UK and not approved in Canada. In Australia it is not approved and is listed as banned in sport (WADA). A research-chemical vial labeled GHRP-2 is not that Japanese test product. This FAQ does not invent a US approval. Full record at /compounds/ghrp-2.
Every FDA-approved compound in the archive, as a list
Studies in people from the compound pages this answer belongs to
- GHRP-2
- A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency 2007 PMID 17609397
- Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men 2005 PMID 15699539
- Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature 1997 PMID 9390009
Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.
Part of growth hormone secretagogues. Sermorelin, tesamorelin, ipamorelin, CJC-1295, and the rest of the GHRH and ghrelin receptor family.